|Fees to non-executive directors||0.6||0.6|
|Share-based payment charge||1.3||1.4|
Further information about the remuneration of individual directors and details of their pension arrangements are provided in the directors' remuneration report.
Remuneration of key management personnel
|Salaries and short-term employee benefits||5.9||5.6|
|Share-based payment charge||2.4||2.5|
Key management personnel comprises all directors and certain senior managers who are members of the executive team.
Employee benefits expense (including directors)
|Wages and salaries||206.5||204.1|
|Defined benefit pension expense (see note 18)||26.2||21.1|
|Defined contribution pension costs (see note 18)||8.8||8.1|
|Charged to regulatory capital schemes||(121.1)||(122.6)|
|Employee benefits expense attributable to continuing operations||145.1||133.7|
* The comparatives have been restated to reflect the requirements of IFRS 11 'Joint Arrangements'. See accounting policies for details.
Within employee benefits expense were £11.0 million (2014: £4.4 million) of restructuring costs.
The total expense included within employee benefits expense from continuing operations in respect of equity-settled share-based payments was £2.9 million (2014: £4.4 million). The company operates several share option schemes, details of which are given in the directors' remuneration report. Further disclosures have not been included as they are considered immaterial to the assessment of the share-based payments charge.
Average number of employees during the year (full-time equivalent including directors)
The company has no employees.